Corrigendum to “Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies” [J Liq Biopsy, 10 (2025), 100442]
Year: 2025
Type: erratum
Abstract: [This corrects the article DOI: 10.1016/j.jlb.2025.100442.].
Source: The Journal of Liquid Biopsy
Authors: Christian D. Rolfo, Moh'd M. Khushman, Alessandro Russo, Roberto Borea, Bernard Herrman, Jing Wang, Jiemin Liao, Carin R. Espenschied, Sean Gordon, Katie Quinn, Kimberly C. Banks, Arielle J. Medford
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Washington University in St. Louis, Humanitas University, Fondazione Humanitas per la Ricerca, Guardant (United States), Harvard University, Massachusetts General Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,080
OpenAlex ID: W7106498805
Cites:
Cited by:
Related to: